Latest News for: p53

Edit

Mynt opens P53-B IPO

The Philadelphia Inquirer 06 Oct 2026
MANILA, Philippines — Mynt Inc., the parent company of the group behind ...
Edit

Mount Sinai Study Uncovers How Loss of the Critical Tumor Suppressor p53 Enables Mutant Cells to Expand Through Normal Tissue (Mount Sinai Health System Inc)

Public Technologies 02 Oct 2026
Mount Sinai Study Uncovers How Loss of the Critical Tumor Suppressor p53 Enables Mutant Cells to Expand Through Normal Tissue ... Loss of the tumor suppressor p53 generates a signaling gradient that drives epithelial clonal expansion.
  • 1

Article Search

tools
×
×
×
×